Rossari Biotech Q2 Revenue ₹697.6 Crore, Up 19%; EBITDA ₹87 Crore, A 20.9% Rise
Mumbai: Rossari Biotech Limited , a specialty chemicals manufacturer, announced its unaudited financial results for the quarter and half-year ended 30 September 2026. The company reported a consolidated revenue of ₹697.6 crore for the second quarter of fiscal year 2027, marking a 19% growth year-on-year. Rossari Biotech Q1 Profit Rises To ₹47 Crore, Revenue Up 28% Financial Performance…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
